Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma

Oral Oncology

Volumn 43, Issue 3, 2007, Pages 283-288

  Lu, Chia Chun ^a   Chang, Kuo Wei ^b   Chou, Feng Chih ^a   Cheng, Chieh Yuan ^a   Liu, Chung Ji ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

Oral squamous cell carcinoma; Platelet; Thrombocytosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TAIWAN; THROMBOCYTE COUNT; THROMBOCYTOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOCYTOSIS;

EID: 33846888774     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.03.010     Document Type: Article

References (30)

1. Riess L. Zur pathologischen Anatomie des Blutes. Arch Anat Physiol Wissensch Med 39 (1872) 237-249
2. Pedersen L.M., and Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9 9 (1996) 1826-1830
3. Aoe K., Hiraki A., Ueoka H., et al. Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 71 2 (2004) 170-173
4. Pedersen L.M., and Milman N. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep 10 1 (2003) 213-216
5. Shimada H., Oohira G., Okazumi S., et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198 5 (2004) 737-741
6. Taucher S., Salat A., Gnant M., et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemostasis 89 6 (2003) 1098-1106
7. Ikeda M., Furukawa H., Imamura H., et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9 3 (2002) 287-291
8. Chen C.C., Chang J.Y., Liu K.J., et al. Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis. Ann Oncol 16 6 (2005) 988-989
9. Brown K.M., Domin C., Aranha G.V., Yong S., and Shoup M. Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas. Am J Surg 189 3 (2005) 278-282
10. Gogus C., Baltaci S., Filiz E., Elhan A., and Beduk Y. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma. Urology 63 3 (2004) 447-450
11. Monreal M., Fernandez-Llamazares J., Pinol M., et al. Platelet count and survival in patients with colorectal cancer-a preliminary study. Thromb Haemostasis 79 5 (1998) 916-918
12. Lopes A., Daras V., Cross P.A., Robertson G., Beynon G., and Monaghan J.M. Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer 74 1 (1994) 90-92
13. Hefler L., Mayerhofer K., Leibman B., et al. Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21 5 (2000) 309-314
14. Gucer F., Moser F., Tamussino K., et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 70 2 (1998) 210-214
15. Cawson R.A., Binnie W.H., and Eveson J.W. Color Atlas of oral disease-clinical and pathological correlations. 2nd ed. (1994), Wolfe, London
16. Symbas N.P., Townsend M.F., El-Galley R., Keane T.E., Graham S.D., and Petros J.A. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 86 3 (2000) 203-207
17. Tranum B.L., and Haut A. Thrombocytosis: platelet kinetics in neoplasia. J Lab Clin Med 84 5 (1974) 615-619
18. Benoy I., Salgado R., Colpaert C., Weytjens R., Vermeulen P.B., and Dirix L.Y. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2 4 (2002) 311-315
19. Kaser A., Brandacher G., Steurer W., et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98 9 (2001) 2720-2725
20. de Sauvage F.J., Hass P.E., Spencer S.D., et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369 6481 (1994) 533-538
21. Kaushansky K., Lok S., Holly R.D., et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369 6481 (1994) 568-571
22. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 86 2 (1995) 419-431
23. Karpatkin S., and Pearlstein E. Role of platelets in tumor cell metastases. Ann Intern Med 95 5 (1981) 636-641
24. Walz D.A. Thrombospondin as a mediator of cancer cell adhesion in metastasis. Cancer Metastasis Rev 11 3-4 (1992) 313-324
25. Tuszynski G.P., Gasic T.B., Rothman V.L., Knudsen K.A., and Gasic G.J. Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res 47 15 (1987) 4130-4133
26. Verheul H.M., Jorna A.S., Hoekman K., Broxterman H.J., Gebbink M.F., and Pinedo H.M. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 96 13 (2000) 4216-4221
27. Yahalom J., Eldor A., Fuks Z., and Vlodavsky I. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J Clin Invest 74 5 (1984) 1842-1849
28. Zacharski L.R. Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy. Cancer Lett 186 1 (2002) 1-9
29. Hejna M., Raderer M., and Zielinski C.C. Inhibition of metastases by anticoagulants. J Natl Cancer Inst 91 1 (1999) 22-36
30. Lemoine N.R. Antithrombotic therapy in cancer. J Clin Oncol 23 10 (2005) 2119-2120